Literature DB >> 20598393

Self-targeting by CRISPR: gene regulation or autoimmunity?

Adi Stern1, Leeat Keren, Omri Wurtzel, Gil Amitai, Rotem Sorek.   

Abstract

The recently discovered prokaryotic immune system known as CRISPR (clustered regularly interspaced short palindromic repeats) is based on small RNAs ('spacers') that restrict phage and plasmid infection. It has been hypothesized that CRISPRs can also regulate self gene expression by utilizing spacers that target self genes. By analyzing CRISPRs from 330 organisms we found that one in every 250 spacers is self-targeting, and that such self-targeting occurs in 18% of all CRISPR-bearing organisms. However, complete lack of conservation across species, combined with abundance of degraded repeats near self-targeting spacers, suggests that self-targeting is a form of autoimmunity rather than a regulatory mechanism. We propose that accidental incorporation of self nucleic acids by CRISPR can incur an autoimmune fitness cost, and this could explain the abundance of degraded CRISPR systems across prokaryotes. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20598393      PMCID: PMC2910793          DOI: 10.1016/j.tig.2010.05.008

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  30 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function.

Authors:  Ken C Pang; Martin C Frith; John S Mattick
Journal:  Trends Genet       Date:  2005-11-10       Impact factor: 11.639

3.  The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes.

Authors:  James S Godde; Amanda Bickerton
Journal:  J Mol Evol       Date:  2006-04-11       Impact factor: 2.395

4.  A putative viral defence mechanism in archaeal cells.

Authors:  Reidun K Lillestøl; Peter Redder; Roger A Garrett; Kim Brügger
Journal:  Archaea       Date:  2006-08       Impact factor: 3.273

Review 5.  CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea.

Authors:  Rotem Sorek; Victor Kunin; Philip Hugenholtz
Journal:  Nat Rev Microbiol       Date:  2008-03       Impact factor: 60.633

Review 6.  CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors:  John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal:  Trends Biochem Sci       Date:  2009-07-29       Impact factor: 13.807

7.  Diversity of CRISPR loci in Escherichia coli.

Authors:  C Díez-Villaseñor; C Almendros; J García-Martínez; F J M Mojica
Journal:  Microbiology       Date:  2010-02-04       Impact factor: 2.777

8.  Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages.

Authors:  Jan R van der Ploeg
Journal:  Microbiology       Date:  2009-04-21       Impact factor: 2.777

9.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

10.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

View more
  163 in total

1.  Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax.

Authors:  André Plagens; Britta Tjaden; Anna Hagemann; Lennart Randau; Reinhard Hensel
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

2.  Nature and intensity of selection pressure on CRISPR-associated genes.

Authors:  Nobuto Takeuchi; Yuri I Wolf; Kira S Makarova; Eugene V Koonin
Journal:  J Bacteriol       Date:  2011-12-16       Impact factor: 3.490

3.  Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system.

Authors:  Kirill A Datsenko; Ksenia Pougach; Anton Tikhonov; Barry L Wanner; Konstantin Severinov; Ekaterina Semenova
Journal:  Nat Commun       Date:  2012-07-10       Impact factor: 14.919

4.  The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction.

Authors:  Rotem Edgar; Udi Qimron
Journal:  J Bacteriol       Date:  2010-10-01       Impact factor: 3.490

Review 5.  CRISPR-Cas adaptation: insights into the mechanism of action.

Authors:  Gil Amitai; Rotem Sorek
Journal:  Nat Rev Microbiol       Date:  2016-01-11       Impact factor: 60.633

Review 6.  The phage-host arms race: shaping the evolution of microbes.

Authors:  Adi Stern; Rotem Sorek
Journal:  Bioessays       Date:  2011-01       Impact factor: 4.345

Review 7.  Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Authors:  Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

8.  Natural Competence and Horizontal Gene Transfer in Campylobacter.

Authors:  Julia Carolin Golz; Kerstin Stingl
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.

Authors:  M A Serbanescu; M Cordova; K Krastel; R Flick; N Beloglazova; A Latos; A F Yakunin; D B Senadheera; D G Cvitkovitch
Journal:  J Bacteriol       Date:  2014-12-08       Impact factor: 3.490

10.  Investigation of direct repeats, spacers and proteins associated with clustered regularly interspaced short palindromic repeat (CRISPR) system of Vibrio parahaemolyticus.

Authors:  Pallavi Baliga; Malathi Shekar; Moleyur Nagarajappa Venugopal
Journal:  Mol Genet Genomics       Date:  2018-10-24       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.